Test Detail
Gordon Setter pack: Hereditary ataxia (HA) and rcd4-PRA
General · Dog
Multi-disease genetic panel for the Gordon Setter grouping two molecular tests for hereditary conditions described in the breed: hereditary ataxia (HA) and rcd4-PRA progressive retinal atrophy. Each condition has its own molecular basis and inheritance. The panel is complementary to the ocular and neurological examination in breeding selection.
Incidence
Applicable breed: Gordon Setter. HA (RAB24) and rcd4-PRA (C2orf71) documented in the breed. Carrier frequencies: limited data.
Breeder management
- Genotype breeding animals before mating; the panel covers two conditions in a single sample
- For both conditions (recessive): do not mate two carriers — 25% risk of homozygous affected; carrier×clear is safe for offspring intended for breeding if tested
- While the HA and rcd4-PRA genes are being confirmed, avoid mating affected animals and keep a genealogical record of lines with cases
- After a confirmed clinical case, do not repeat the parental mating and communicate the status to the buyer
- For both conditions (recessive): do not mate two carriers — 25% risk of homozygous affected; carrier×clear is safe for offspring intended for breeding if tested
- While the HA and rcd4-PRA genes are being confirmed, avoid mating affected animals and keep a genealogical record of lines with cases
- After a confirmed clinical case, do not repeat the parental mating and communicate the status to the buyer
Specialist notes
HA must be differentiated from other cerebellar ataxias and from acquired causes (infectious, toxic, neoplastic, vitamin E deficiency). rcd4-PRA is confirmed by ocular examination and molecular test; annual examination (ECVO/CERF) complementary.
References
1. Agler C et al. 2014, ataxia hereditaria por RAB24 en Bobtail y Gordon setter (PMID 24516392)
2. Downs LM et al. 2013, PRA de inicio tardĂo por C2orf71 en Gordon e Irish setter (PMID 22686255)
2. Downs LM et al. 2013, PRA de inicio tardĂo por C2orf71 en Gordon e Irish setter (PMID 22686255)